1. Home
  2. AAOI vs ABVX Comparison

AAOI vs ABVX Comparison

Compare AAOI & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Optoelectronics Inc.

AAOI

Applied Optoelectronics Inc.

SELL

Current Price

$106.25

Market Cap

14.8B

Sector

Technology

ML Signal

SELL

Logo Abivax SA American

ABVX

Abivax SA American

BUY

Current Price

$89.05

Market Cap

11.9B

Sector

N/A

ML Signal

BUY

Company Overview

Basic Information
Metric
AAOI
ABVX
Founded
1997
2013
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
11.9B
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
AAOI
ABVX
Price
$106.25
$89.05
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$163.40
★ $164.00
AVG Volume (30 Days)
★ 6.4M
1.3M
Earning Date
11-05-2026
09-21-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 85.78
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$127.87
N/A
Revenue Next Year
$156.48
$1,702.77
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.50
$69.81
52 Week High
$233.67
$148.83

Technical Indicators

Market Signals
Indicator
AAOI
ABVX
Relative Strength Index (RSI) 47.77 30.25
Support Level $95.70 $74.79
Resistance Level $115.46 $128.68
Average True Range (ATR) 7.57 4.08
MACD 2.37 -0.74
Stochastic Oscillator 32.80 14.97

Price Performance

Historical Comparison
AAOI
ABVX

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to meet turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: